Biomarkers for Homologous Recombination Deficiency in Cancer
DNA double-strand breaks foster tumorigenesis and cell death. Two distinct mechanisms can be activated by the cell for DNA repair: the accurate mechanism of homologous recombination repair or the error-prone non-homologous end joining. Homologous Recombination Deficiency (HRD) is associated with sen...
Main Authors: | Svenja Wagener-Ryczek, Sabine Merkelbach-Bruse, Janna Siemanowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/7/612 |
Similar Items
-
Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
by: Marjolijn M. Ladan, et al.
Published: (2021-02-01) -
A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining
by: Sylvie Moureau, et al.
Published: (2016-01-01) -
Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma
by: Zhiwen Shi, et al.
Published: (2021-05-01) -
SUMO Wrestles with Recombination
by: Lumír Krejčí, et al.
Published: (2012-07-01) -
Expression of EhRAD54, EhRAD51, and EhBLM proteins during DNA repair by homologous recombination in Entamoeba histolytica
by: del Socorro Charcas-Lopez Ma., et al.
Published: (2014-01-01)